CoChat

Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal Cell Carcinoma

Open access

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Abstract

In renal cell carcinoma (RCC), single members of the Wnt/β-catenin signaling cascade were recently identified to contribute to cancer progression. However, the role of Wnt1, one of the key ligands in β-catenin regulation, is currently unknown in RCC. Therefore, alterations of the Wnt1/β-catenin axis in clear cell RCC (ccRCC) were examined with regard to clinicopathology, overall survival (OS) and cancer specific survival (CSS). Corresponding ccRCCs and benign renal tissue were analyzed in 278 patients for Wnt1 and β-catenin expression by immunohistochemistry in tissue microarrays. Expression scores, including intensity and percentage of stained cells, were compared between normal kidney and ccRCCs. Data was categorized according to mean expression scores and correlated to tumor and patients’ characteristics. Survival was analyzed according to the Kaplan-Meier and log-rank test. Univariable and multivariable Cox proportional hazard regression models were used to explore the independent prognostic value of Wnt1 and β-catenin. In ccRCCs, high Wnt1 was associated with increased tumor diameter, stage and vascular invasion (p ≤ 0.02). High membranous β-catenin was associated with advanced stage, vascular invasion and tumor necrosis (p ≤ 0.01). Higher diameter, stage, node involvement, grade, vascular invasion and sarcomatoid differentiation (p ≤ 0.01) were found in patients with high cytoplasmic β-catenin. Patients with a high cytoplasmic β-catenin had a significantly reduced OS (hazard ratio (HR) 1.75) and CSS (HR 2.26), which was not independently associated with OS and CSS after adjustment in the multivariable model. Increased ccRCC aggressiveness was reflected by an altered Wnt1/β-catenin signaling. Cytoplasmic β-catenin was identified as the most promising candidate associated with unfavorable clinicopathology and impaired survival. Nevertheless, the shift of membranous β-catenin to the cytoplasm with a subsequently increased nuclear expression, as shown for other malignancies, could not be demonstrated to be present in ccRCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms140610944

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Representative immunohistochemical staining of Wnt1 and β-catenin in normal renal and ccRCC tissues.
Figure 1 Representative immunohistochemical staining of Wnt1 and β-catenin in normal renal and ccRCC tissues.CC BY · PubMed Central
Figure 2 Kaplan-Meier survival analysis of Wnt1, membranous β-Catenin and cytoplasmic β-Catenin accumulative effects on overall survival and cancer-specific survival (log rank analysis). Patients were categorized by mean immunohistochemical (IHC) protein expression scores (blue line ≤ mean IHC score; green line > mean IHC score).
Figure 2 Kaplan-Meier survival analysis of Wnt1, membranous β-Catenin and cytoplasmic β-Catenin accumulative effects on overall survival and cancer-specific survival (log rank analysis). Patients were categorized by mean immunohistochemical (IHC) protein expression scores (blue line ≤ mean IHC score; green line > mean IHC score).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Aaltomaa, 2004, The expression and prognostic value of α-, β- and γ-catenins in renal cell carcinoma, Anticancer Res, 24, 2407

Cited by

See all 75

Metadata

Authors
Kruck, S., Eyrich, C., Scharpf, M., Sievert, K.-D., Fend, F., Stenzl, A., & Bedke, J.
Affiliations
University of Tübingen (DE)
Corresponding author
Bedke, Jens
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2013-05-24
Volume
14
Issue
6
Pages
10944-10957
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2016373982
Cited by
70
References
42
Citations by year
2026: 1 · 2025: 6 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 10 · 2020: 9 · 2019: 6 · 2018: 4 · 2017: 7 · 2016: 8 · 2015: 2 · 2014: 3 · 2013: 2
FWCI
4.06
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Oncology › Renal and related cancers
Keywords
clear cell renal cell carcinoma, Wnt1, β-catenin, Wnt/β-catenin signaling, prognostic factors, overall survival, cancer-specific survival, clinicopathological features, vascular invasion, sarcomatoid differentiation, nuclear beta-catenin expression
MeSH terms
Carcinoma, Renal Cell, Cell Membrane, Cytoplasm, Female, Humans, Immunohistochemistry, Kidney, Kidney Neoplasms, Male, Middle Aged, Prognosis, Multivariate Analysis, Proportional Hazards Models, Disease-Free Survival, Wnt1 Protein, beta Catenin, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.